PEDIATRICS Vol. 109 No. 5 May 2002, pp. 839-845
Hepatitis A Virus Infections in the United States: Model-Based Estimates and Implications for Childhood Immunization
From the Epidemiology Branch, Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
--> Objective. The high prevalence of antibody to hepatitis A virus (HAV) in the US population suggests that the incidence of infection is much higher than reported, but the infection rate is difficult to measure directly because of anicteric infection and underreporting. We present a model that reconciles the reported incidence of hepatitis A with the observed prevalence of antibody to HAV and provides an estimate of the true incidence of HAV infection.
Methods. In the model, reported incidence of hepatitis A in the United States was adjusted to account first for anicteric infection and then for underreporting and declining incidence over time such that the prevalence predicted by the model approximated that observed in 2 nationwide surveys.
Results. The model showed incidence in the susceptible population declining by 4.5% per year. As incidence declined early in the 1900s, the average age at infection increased, leading to a paradoxical increase in the incidence of icteric infection followed by a slow decline. The model estimated approximately 270 000 (range: 190 000–360 000) infections annually from 1980 to 1999, 10.4 times the number of hepatitis A cases actually reported during this period. More than half of these infections occurred in children who were younger than 10 years, most of which would have been clinically unrecognizable as hepatitis.
Conclusions. These results suggest a large reservoir of infection in children and that interruption of transmission in children may substantially reduce incidence of hepatitis A overall.
Key Words: hepatitis A • statistical models • incidence
Abbreviations: HAV, hepatitis A virus • anti-HAV, antibody to hepatitis A virus • NHANES, National Health and Nutrition Examination Survey • CI, confidence interval • CL confidence limit
Received for publication Oct 10, 2001; Accepted Jan 8, 2002.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  S. W. Roush, T. V. Murphy, and and the Vaccine-Preventable Disease Table Working Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States JAMA, November 14, 2007; 298(18): 2155 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Committee on Infectious Diseases Hepatitis A Vaccine Recommendations Pediatrics, July 1, 2007; 120(1): 189 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Rein, K. A. Hicks, K. E. Wirth, K. Billah, L. Finelli, A. E. Fiore, T. J. Hoerger, B. P. Bell, and G. L. Armstrong Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States Pediatrics, January 1, 2007; 119(1): e12 - e21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Armstrong, K. Billah, D. B. Rein, K. A. Hicks, K. E. Wirth, and B. P. Bell The Economics of Routine Childhood Hepatitis A Immunization in the United States: The Impact of Herd Immunity Pediatrics, January 1, 2007; 119(1): e22 - e29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wasley, A. Fiore, and B. P. Bell Hepatitis A in the Era of Vaccination Epidemiol. Rev., August 1, 2006; 28(1): 101 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L Temte Should all children be immunised against hepatitis A? BMJ, March 25, 2006; 332(7543): 715 - 718. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Victor, T. Y. Surdina, S. Z. Suleimenova, M. O. Favorov, B. P. Bell, and A. S. Monto Person-to-Person Transmission of Hepatitis A Virus in an Urban Area of Intermediate Endemicity: Implications for Vaccination Strategies Am. J. Epidemiol., February 1, 2006; 163(3): 204 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. V. Nainan, G. Xia, G. Vaughan, and H. S. Margolis Diagnosis of Hepatitis A Virus Infection: a Molecular Approach Clin. Microbiol. Rev., January 1, 2006; 19(1): 63 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Schiff Decline of Hepatitis A in the US: Another Vaccine Success Story AAP Grand Rounds, October 1, 2005; 14(4): 37 - 38. [Full Text] [PDF]
|
|
|
|
|
|
Positive Test Results for Acute Hepatitis A Virus Infection Among Persons With No Recent History of Acute Hepatitis--United States, 2002-2004 JAMA, August 24, 2005; 294(8): 894 - 896. [Full Text] [PDF]
|
|
|
|
|
|
A. Wasley, T. Samandari, and B. P. Bell Incidence of Hepatitis A in the United States in the Era of Vaccination JAMA, July 13, 2005; 294(2): 194 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dagan, A. Leventhal, E. Anis, P. Slater, Y. Ashur, and D. Shouval Incidence of Hepatitis A in Israel Following Universal Immunization of Toddlers JAMA, July 13, 2005; 294(2): 202 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. El-Kamary and T. L. Cheng Hepatitis A Pediatr. Rev., February 1, 2005; 26(2): 75 - 76. [Full Text] [PDF]
|
|
|
|
|
|
M. Weinberg, J. Hopkins, L. Farrington, L. Gresham, M. Ginsberg, and B. P. Bell Hepatitis A in Hispanic Children Who Live Along the United States-Mexico Border: The Role of International Travel and Food-Borne Exposures Pediatrics, July 1, 2004; 114(1): e68 - e73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Craig and W. Schaffner Prevention of Hepatitis A with the Hepatitis A Vaccine N. Engl. J. Med., January 29, 2004; 350(5): 476 - 481. [Full Text] [PDF]
|
|
|
|
|
|
B. Bardenheier, I. M. Gonzalez, M. L. Washington, B. P. Bell, F. Averhoff, M. S. Massoudi, I. Hyams, E. P. Simard, and H. Yusuf Parental Knowledge, Attitudes, and Practices Associated With Not Receiving Hepatitis A Vaccine in a Demonstration Project in Butte County, California Pediatrics, October 1, 2003; 112(4): e269 - 269. [Abstract] [Full Text] [PDF]
|
|
